Document:

exv10w1

Exhibit 10.1

This
Securities Purchase Agreement (the “Purchase Agreement”) contains representations and warranties that
the Investors (“Investors”) and Insulet Corporation (“Insulet”) made to each other. These
representations and warranties were made only for the purposes of the signing of the Purchase
Agreement and solely for the benefit of the Investors and Insulet as of specific dates, may be
subject to important limitations and qualifications agreed to by the Investors and Insulet in
connection with the signing of the Purchase Agreement, and may not be complete. Furthermore, these
representations and warranties may have been made for the purposes of allocating contractual risk
between the Investors and Insulet instead of establishing these matters as facts, and may or may
not have been accurate as of any specific date and do not purport to be accurate as of the date of
the filing of the Purchase Agreement by Insulet with the Securities and Exchange Commission.
Accordingly, you should not rely upon the representations and warranties contained in the Purchase
Agreement as characterizations of the actual state of facts, since they were intended to be for the
benefit of, and to be limited to, the Investors and Insulet.

SECURITIES PURCHASE AGREEMENT

     This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of September 25, 2009,
is by and among Insulet Corporation, a Delaware corporation (the “Company”), Deerfield
Private Design Fund, L.P. (“DPDF”), Deerfield Private Design International, L.P.
(“DPDI”), Deerfield Partners, L.P. (“DP”), and Deerfield International Limited
(collectively with DPDF, DPDI and DP, the “Investors”).

RECITALS

     WHEREAS, the Company has filed with the Securities and Exchange Commission (the
“Commission”) the Registration Statement (as defined below) relating to the offer and sale
from time to time of the Company’s securities, including shares of its common stock, par value
$0.001 per share (the “Common Stock”);

     WHEREAS, the Company is offering for sale shares of Common Stock (the “Offered
Shares”) pursuant to the Registration Statement;

     WHEREAS, the Investors desire to purchase from the Company Offered Shares on the terms and
conditions set forth herein; and

     WHEREAS, on the date hereof, the Company and the Investors have entered into an Amendment to
the Facility Agreement, dated as of March 13, 2009 (as amended, the “Facility Agreement”).

AGREEMENT

     NOW, THEREFORE, in consideration of the foregoing recitals (which are deemed to be a part of
this Agreement), mutual covenants, representations, warranties and agreements contained herein and
other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:

     1. Definitions. As used herein, the following terms have the meanings indicated:

          “Business Day” means any day other than Saturday, Sunday or a day on which banks in
the City of New York are authorized or required to be closed.

 

 

          “knowledge” means with respect to any statement made to the Company’s knowledge, that
statement is based upon the actual knowledge of Duane DeSisto, the Company’s President and Chief
Executive Officer, Brian Roberts, the Company’s Chief Financial Officer and R. Anthony Diehl, the
Company’s General Counsel.

          “Loss” shall have the meaning set forth in Section 5 hereof.

          “Person” shall mean any individual, partnership, limited liability company, joint
venture, firm, corporation, association, trust or other enterprise or any government or political
subdivision or any agency, department or instrumentality thereof.

          “Prospectus” shall have the meaning set forth in Section 4(b)(6) hereof.

          “Prospectus Supplement” shall mean the prospectus supplement filed with the Commission
pursuant to Rule 424(b) promulgated under the Securities Act (“Rule 424(b)”) and deemed to
be part of the Registration Statement at the time of effectiveness.

          “Registration Statement” shall mean the registration statement on Form S-3 (File No.
333-158354), including a prospectus, and including all amendments and supplements thereto
(including the Prospectus Supplement), relating to the offer and sale of certain of the Company’s
Common Stock, including the Investor Shares. References herein to the term “Registration
Statement” as of any date shall mean such effective registration statement, as amended or
supplemented to such date, including all information and documents incorporated by reference
therein as of such date.

          “SEC” shall mean the Securities and Exchange Commission.

          “Securities Act” shall mean the Securities Act of 1933, as amended.

     2. Purchase of Common Stock. Subject and pursuant to the terms and conditions set
forth in this Agreement, the Company agrees that it will issue and sell to the Investors, and the
Investors agree that they will purchase from the Company, the number of Offered Shares set forth on
Schedule I attached hereto (the “Investor Shares”). The aggregate purchase price
for the Investor Shares (the “Aggregate Purchase Price”) and the purchase price per
Investor Share is set forth on Schedule I hereto. The closing of the purchase and sale of
the Investor Shares will take place on or before the fifteenth (15th) Business Day
following the date of this Agreement, or such other date or time as the parties may agree upon in
writing (the “Closing”).

     3. Deliveries at Closing.

          (a) Deliveries by the Investor. At the Closing, each Investor shall deliver to the
Company the Aggregate Purchase Price set forth next to their name on Schedule I hereto by
wire transfer of immediately available funds to a bank account designated in writing by the Company
to the Investors, which funds will be delivered to the Company in consideration of the Investor
Shares issued at the Closing.

          (b) Deliveries by the Company. At the Closing, the Company shall deliver to each
Investor duly issued stock certificates representing the Investor Shares.

2

 

     4. Representations, Warranties, Covenants and Agreements.

          (a) Investor Representations, Warranties and Covenants. Each Investor represents,
warrants, covenants and agrees as follows as of the date hereof and as of the Closing:

               (1) Investor has received and reviewed copies of the Registration Statement and the
Prospectus, including all documents and information incorporated by reference therein and
amendments thereto, and understands that no Person has been authorized to give any information or
to make any representations that were not contained in the Registration Statement and the
Prospectus, and Investor has not relied on any such other information or representations in making
a decision to purchase the Investor Shares. Investor hereby consents to receiving delivery of the
Registration Statement and the Prospectus, including all documents and information incorporated by
reference therein and amendments thereto, by electronic mail. Investor understands that an
investment in the Company involves a high degree of risk for the reasons, among others, set forth
under the caption “Risk Factors” in the Prospectus.

               (2) Investor acknowledges that it has sole responsibility for its own due diligence
investigation and its own investment decision, and that in connection with its investigation of the
accuracy of the information contained or incorporated by reference in the Registration Statement
and the Prospectus and its investment decision, Investor has not relied on any representation or
information, as the case may be, not set forth in this Agreement, the Registration Statement or the
Prospectus, or any Person affiliated with the Company or on the fact that any other Person has
decided to purchase the Offered Shares.

               (3) The execution and delivery of this Agreement by Investor and the performance of this
Agreement and the consummation by Investor of the transactions contemplated hereby have been duly
authorized by all necessary corporate or partnership action of Investor, as applicable, and this
Agreement, when duly executed and delivered by Investor, will constitute a valid and legally
binding instrument, enforceable in accordance with its terms against Investor, except as
enforcement hereof may be limited by the effect of any applicable bankruptcy, insolvency,
reorganization or similar laws or court decisions affecting enforcement of creditors’ rights
generally and except as enforcement hereof is subject to general principles of equity (regardless
of whether enforcement is considered in a proceeding in equity or at law).

          (b) Company Representations, Warranties and Covenants. The Company hereby represents,
warrants, covenants and agrees as follows as of the date hereof and as of the Closing:

               (1) The Company has been duly incorporated and has a valid existence and the authorization to
transact business as a corporation under the laws of the State of Delaware, with corporate power
and authority to own its properties and conduct its business as described in the Prospectus, and
has been duly qualified as a foreign corporation for the transaction of business and is in good
standing under the laws of each other jurisdiction in which it owns or leases properties or
conducts any business so as to require such qualification, except for such jurisdictions wherein
the failure to be so qualified and in good standing would not individually or in the aggregate have
a material adverse effect on the business, results of operations or financial condition of the
Company and its subsidiaries taken as a whole (a “Material Adverse Effect”).

3

 

               (2) Each subsidiary of the Company has been duly incorporated and is validly existing as a
corporation in good standing under the laws of its jurisdiction of incorporation, with corporate
power and authority to own its properties and conduct its business as described in the Prospectus,
and has been duly qualified as a foreign corporation for the transaction of business and is in good
standing under the laws of each other jurisdiction in which it owns or leases properties or
conducts any business so as to require such qualification, except for such jurisdictions wherein
the failure to be so qualified and in good standing would not individually or in the aggregate have
a Material Adverse Effect. All subsidiaries and their respective jurisdictions of incorporation
are identified on Schedule II hereto. Except as disclosed in Schedule II, all of
the outstanding capital stock or other voting securities of each subsidiary is owned by the
Company, directly or indirectly, free and clear of any lien and free of any other limitation or
restriction (including any restriction on the right to vote, sell or otherwise dispose of such
capital stock or other voting securities). Except as disclosed by the Company’s periodic reports
filed with the SEC, there are no outstanding (i) securities of the Company or any of the
subsidiaries of the Company which are convertible into or exchangeable for shares of capital stock
or voting securities of any subsidiary of the Company or (ii) options or other rights to acquire
from the Company or any subsidiary of the Company, or other obligation of the Company or any
subsidiary of the Company to issue, any capital stock, voting securities or securities convertible
into or exchangeable for capital stock or voting securities of any subsidiary of the Company
(collectively, the “Subsidiary Securities”). There are no outstanding obligations of the
Company or any subsidiary of the Company to repurchase, redeem or otherwise acquire any outstanding
Subsidiary Securities.

               (3) The execution, delivery and performance of this Agreement by the Company and the
consummation of the transactions contemplated hereby are within the corporate powers of the Company
and have been duly authorized by all necessary corporate action on the part of the Company and this
Agreement, when duly executed and delivered by the parties hereto, will constitute a valid and
legally binding instrument of the Company enforceable in accordance with its terms, except as
enforcement hereof may be limited by the effect of any applicable bankruptcy, insolvency,
reorganization or similar laws or court decisions affecting enforcement of creditors’ rights
generally and except as enforcement hereof is subject to general principles of equity (regardless
of whether enforcement is considered in a proceeding in equity or at law).

               (4) The Investor Shares have been duly authorized by the Company, and when issued and
delivered by the Company against payment therefor as contemplated by this Agreement, the Investor
Shares will be validly issued, fully paid and nonassessable, and will conform to the description of
the Common Stock contained in the Prospectus.

               (5) The execution and delivery of this Agreement do not, and the compliance by the Company
with the terms hereof will not, (i) violate the Certificate of Incorporation (as amended to date)
of the Company or the By-Laws (as amended to date) of the Company, (ii) result in a breach or
violation of any of the terms or provisions of, or constitute a material default under, any
indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the
Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is
bound or to which any of their properties or assets are subject, or (iii) result in a violation of,
or failure to be in compliance with, any applicable statute

4

 

or any order, judgment, decree, rule or regulation of any court or governmental, regulatory or
self-regulatory agency or body having jurisdiction over the Company or any of its subsidiaries or
any of their properties or assets, except where such breach, violation, default or the failure to
be in compliance would not individually or in the aggregate have a Material Adverse Effect or
adversely affect the ability of the Company to issue and sell the Investor Shares; and no consent,
approval, authorization, order, registration, filing or qualification of or with any such court or
governmental, regulatory or self-regulatory agency or body is required for the valid authorization,
execution, delivery and performance by the Company of this Agreement or the issuance of the
Investor Shares, except for the filing of the Prospectus Supplement, the filing of a Notification
of Listing of Additional Shares with The NASDAQ Stock Market LLC, and for such consents, approvals,
authorizations, registrations, filings or qualifications as may be required under state securities
or “blue sky” laws.

               (6) The Company meets the requirements for use of Form S-3 under the Securities Act. The
Registration Statement, which covers the Investor Shares, including a form of prospectus and such
amendments or supplements to such Registration Statement as may have been required prior to the
date of this Agreement, has been prepared by the Company under the provisions of the Securities
Act, has been filed with the Commission, has become effective and filed with the Commission and
incorporates by reference documents which the Company has filed in accordance with the provisions
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company has
prepared a Prospectus Supplement to the prospectus included in the Registration Statement referred
to above and the documents incorporated by reference therein, setting forth the terms of the
offering, sale and plan of distribution of the Investor Shares and additional information
concerning the Company and its business and will promptly file the Prospectus Supplement with the
Commission pursuant to Rule 424(b). No stop order suspending the effectiveness of the Registration
Statement or any post-effective amendment thereto, or any part thereof, has been issued and served
on the Company, and no proceedings for that purpose are pending or, to the knowledge of the
Company, threatened by the Commission. Copies of such Registration Statement and prospectus, any
such amendment or supplement and all documents incorporated by reference therein that were filed
with the Commission on or prior to the date of this Agreement have been delivered to the Investor.
The final form of prospectus included in the Registration Statement, as amended or supplemented
from time to time (including the Prospectus Supplement), is referred to herein as the
“Prospectus.” Any reference herein to the Registration Statement, the Prospectus or any
amendment or supplement thereto shall be deemed to refer to and include the documents incorporated
(or deemed to be incorporated) by reference therein, and any reference herein to the terms “amend,”
“amendment” or “supplement” with respect to the Registration Statement or Prospectus shall be
deemed to refer to and include the filing after the execution hereof of any document with the
Commission deemed to be incorporated by reference therein. As of the close of business on
September 24, 2009, at least a number of shares of Common Stock equal to the number of Investor
Shares were available for issuance pursuant to the Registration Statement, which permits the sale
of the Investor Shares in the manner contemplated by this Agreement.

     Each part of the Registration Statement, when such part became or becomes effective, and the
Prospectus and any amendment or supplement thereto, on the date of filing thereof with the
Commission and at the date hereof and the date of the Closing, did or will in all material respects
comply with all applicable provisions of the Securities Act and the Exchange Act. Each

5

 

part of the Registration Statement, when such part became or becomes effective, did not or
will not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary in order to make the statements therein not misleading. The
Prospectus and any amendment or supplement thereto, on the date of filing thereof with the
Commission, did not or will not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading; and any statutes, regulations, contracts or other documents
that are required to be described in the Registration Statement or the Prospectus or to be filed as
exhibits to the Registration Statement have been so described or filed. The foregoing
representations and warranties in this Section 4(b)(6) do not apply to any statements or
omissions made in reliance on and in conformity with information relating to the Investors
furnished in writing to the Company by the Investors specifically for inclusion in the Registration
Statement or Prospectus or any amendment or supplement thereto.

     The documents which are incorporated by reference in the Registration Statement or the
Prospectus, or any amendment or supplement thereto, or from which information is so incorporated by
reference, when they became effective or were filed with the Commission, as the case may be,
complied in all material respects with the requirements of the Securities Act or the Exchange Act,
as applicable, and none of such documents contained an untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary to make the statements
therein not misleading or omitted to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading
and any further documents so filed and incorporated by reference shall, when they become effective
under the Securities Act or when they are filed with the Commission, conform in all material
respects with the requirements of the Securities Act or the Exchange Act, as applicable, and will
not contain an untrue statement of a material fact or omit to state a material fact necessary to
make the statements therein, in the light of the circumstances under which they were made, not
misleading.

               (7) The consolidated financial statements and financial schedules of the Company included or
incorporated by reference in the Registration Statement and the Prospectus have been prepared in
conformity with generally accepted accounting principles (except, with respect to the unaudited
consolidated financial statements, for the footnotes and subject to customary audit adjustments)
applied on a consistent basis, are consistent in all material respects with the books and records
of the Company, and accurately present in all material respects the consolidated financial
position, results of operations and cash flow of the Company and its subsidiaries as of and for the
periods covered thereby.

               (8) [Intentionally Omitted.]

               (9) Neither the Company nor any of its subsidiaries has sustained since the respective dates
of the latest audited financial statements included in the Registration Statement and Prospectus
any material loss or interference with its business from fire, explosion, flood or other calamity,
whether or not covered by insurance, or from any labor dispute or court or governmental action,
order or decree, otherwise than as disclosed in or contemplated by the Registration Statement and
Prospectus; and, since the respective dates as of which information is

6

 

given in the Registration Statement and Prospectus, there has not been any material change in
the capital stock or long-term debt of the Company or any of its subsidiaries.

               (10) Other than as disclosed in the Prospectus, there are no legal, governmental or regulatory
proceedings pending to which the Company or any of its subsidiaries is a party or of which any
material property of the Company or any of its subsidiaries is the subject which, taking into
account the likelihood of the outcome, the damages or other relief sought and other relevant
factors, would individually or in the aggregate reasonably be expected to have a Material Adverse
Effect or adversely affect the ability of the Company to issue and sell the Investor Shares, and no
such proceedings are threatened in writing to the Company or, to the Company’s knowledge, have been
contemplated by governmental or regulatory authorities or threatened by others.

               (11) The Company and each of its subsidiaries have good and marketable title to all the real
property, and owns all other properties and assets, reflected as owned in the financial statements
included in the Registration Statement and the Prospectus, subject to no lien, mortgage, pledge,
charge or encumbrance of any kind except those, if any, reflected in such financial statements, in
favor of the Investors in connection with the Facility Agreement and all amendments thereto, or
which are not material to the Company and its subsidiaries taken as a whole. The Company and each
of its subsidiaries hold their respective leased real and personal properties under valid and
binding leases, except where the failure to do so would not reasonably be expected to individually
or in the aggregate have a Material Adverse Effect.

               (12) The Company has filed all necessary federal and state income and franchise tax returns
and has paid all taxes shown as due thereon or has filed all necessary extensions, and there is no
tax deficiency that has been, or to the knowledge of the Company might be, asserted against the
Company or any of its properties or assets that would in the aggregate or individually reasonably
be expected to have a Material Adverse Affect.

               (13) There are no holders of securities of the Company having preemptive rights to purchase
Common Stock. There are no holders or beneficial owners of securities of the Company having rights
to registration thereof whose securities have not been previously registered or who have not waived
such rights with respect to the registration of the Company’s securities on the Registration
Statement, except where the failure to obtain such waiver would not individually or in the
aggregate reasonably be expected to have a Material Adverse Effect.

               (14) The Company has not taken and will not take any action that constitutes or is designed to
cause or result, or which might reasonably be expected to cause or result, under the Exchange Act
or otherwise, in stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Offered Shares.

               (15) Other than as disclosed in the Prospectus, the Company together with its subsidiaries
owns and possesses all right, title and interest in and to, or has duly licensed from third
parties, all patents, patent rights, trade secrets, inventions, know-how, trademarks, trade names,
copyrights, service marks and other proprietary rights (“Intellectual Property”)

7

 

material to the business of the Company and each of its subsidiaries taken as a whole as
currently conducted and as described in the Prospectus. Except as disclosed in the Company’s
periodic reports filed with the SEC, neither the Company nor any of its subsidiaries has received
any notice of infringement or misappropriation from any third party that has not been resolved or
disposed of and, to the Company’s knowledge, neither the Company nor any of its subsidiaries has
infringed or misappropriated the Intellectual Property of any third party, which infringement or
misappropriation would individually or in the aggregate have a Material Adverse Effect. Further,
there is no pending or, to the Company’s knowledge and except as would not individually or in the
aggregate have a Material Adverse Effect, threatened action, suit, proceeding or claim by
governmental authorities or others that the Company is infringing a patent, and there is no pending
or, to the Company’s knowledge and except as would not individually or in the aggregate have a
Material Adverse Effect, threatened legal or administrative proceeding relating to patents and
patent applications of the Company, other than proceedings initiated by the Company before the
United States Patent and Trademark Office and the patent offices of certain foreign jurisdictions
which are in the ordinary course of patent prosecution. To the Company’s knowledge, the patent
applications of the Company presently on file disclose patentable subject matter, and the Company
is not aware of any inventorship challenges, any interference which has been declared or provoked,
or any other material fact that (i) would preclude the issuance of patents with respect to such
applications or (ii) would lead such counsel to conclude that such patents, when issued, would not
be valid and enforceable in accordance with applicable regulations.

               (16) [Intentionally Omitted.]

               (17) The Company is not, and does not intend to conduct its business in a manner in which it
would become, an “investment company” as defined in Section 3(a) of the Investment Company Act of
1940, as amended.

               (18) All offers and sales of the Company’s capital stock prior to the date hereof were at all
relevant times registered pursuant to the Securities Act or exempt from the registration
requirements of the Securities Act and were duly registered with or the subject of an available
exemption from the registration requirements of the applicable state securities or blue sky laws,
except where the failure to do so would not individually or in the aggregate reasonably be expected
to have a Material Adverse Effect.

               (19) The Company has filed with The NASDAQ Stock Market LLC a Notification of Listing of
Additional Shares with respect to the Investor Shares within the time period required by the rules
of the Nasdaq Global Market, and the Investor Shares have been approved for listing on the Nasdaq
Global Market.

     5. Indemnification.

          (a) Subject to the limitations and other provisions of this Section 5, the Company
covenants and agrees to indemnify, defend and hold harmless the Investors and their respective
directors, officers, partners, managers, employees and agents (each, an “Investor Party”)
from and against any and all Losses resulting from, incurred in connection with or arising out of
(a) any breach of any representation, warranty or covenant of the Company contained herein, or (b)

8

 

the failure of the Company to perform any of the agreements, covenants or obligations
contained herein (other than if any such claim was a result of a breach by the Investor under this
Agreement). Subject to the limitations and other provisions of this Section 5, the
Investor covenants and agrees to indemnify, defend and hold harmless the Company from and against
(but only to the extent of) any and all Losses resulting from, incurred in connection with or
arising out of (but only to the extent of) (a) any breach of any representation or warranty of the
Investor contained herein, or (b) the failure of the Investor to perform any of the agreements,
covenants or obligations of the Investor contained herein. The term “Loss” or any similar
term shall mean any and all damages, deficiencies, costs, claims, fines, judgments, amounts paid in
settlement, expenses of investigation, interest, penalties, taxes, assessments, out-of-pocket
expenses (including reasonable attorneys’ and auditors’ fees and disbursements, witness fees and
court costs) but specifically excluding consequential, special, punitive, multiple and other
similar damages. The party or parties being indemnified are referred to herein as the
“Indemnitee” and the indemnifying party is referred to herein as the “Indemnitor.”

          (b) Indemnification Procedure.

               (1) Any party who receives notice of a potential claim that may, in the judgment of such
party, result in a Loss shall use all reasonable efforts to provide the parties hereto notice
thereof, provided that failure or delay or alleged delay in providing such notice shall not
adversely affect such party’s right to indemnification hereunder, unless and then only to the
extent that such failure or delay or alleged delay has resulted in actual prejudice to the
Indemnitor, including, without limitation, by the expiration of a statute of limitations. In the
event that any party shall incur or suffer any Losses in respect of which indemnification may be
sought by such party hereunder, the Indemnitee shall assert a claim for indemnification by written
notice (a “Notice”) to the Indemnitor stating the nature and basis of such claim. In the
case of Losses arising by reason of any third party claim, the Notice shall be given within fifteen
(15) days of the filing or other written assertion of any such claim against the Indemnitee, but
the failure of the Indemnitee to give the Notice within such time period shall not relieve the
Indemnitor of any liability that the Indemnitor may have to the Indemnitee, except to the extent
that the Indemnitor demonstrates that the defense of such action has been prejudiced by the
Indemnitee’s failure to timely give such Notice.

               (2) In the case of third party claims for which indemnification is sought, the Indemnitor
shall, if necessary, retain counsel reasonably satisfactory to the Indemnitee, it being agreed that
Goodwin Procter LLP is satisfactory, and have the option (i) to conduct any proceedings or
negotiations in connection therewith, (ii) to take all other steps to settle or defend any such
claim (provided that the Indemnitor shall not settle any such claim without the consent of the
Indemnitee which consent shall not be unreasonably withheld or delayed) and (iii) to employ counsel
to contest any such claim or liability in the name of the Indemnitee or otherwise. In any event,
the Indemnitee shall be entitled to participate at its own expense and by its own counsel in any
proceedings relating to any third party claim. The Indemnitor shall, within fifteen (15) Business
Days of receipt of the Notice, notify the Indemnitee of its intention to assume the defense of such
claim. If (i) the Indemnitor shall decline to assume the defense of any such claim, (ii) the
Indemnitor shall fail to notify the Indemnitee within fifteen (15) Business Days after receipt of
the Notice of the Indemnitor’s election to defend such claim, (iii) the Indemnitee shall have
reasonably concluded based on

9

 

discussions with counsel that there may be defenses available to it which are different from
or in addition to those available to the Indemnitor (in which case the Indemnitor shall not have
the right to direct the defense of such action on behalf of the Indemnitee), or (iv) a conflict
exists between the Indemnitor and the Indemnitee which the Indemnitee has reasonably concluded
would prejudice the Indemnitor’s defense of such action, then in each such case the Indemnitor
shall not have the right to direct the defense of such action on behalf of the Indemnitee and the
Indemnitee shall, at the sole expense of the Indemnitor, defend against such claim and (x) in the
event of a circumstance described in clause (i) and (ii), the Indemnitee may settle such claim
without the consent of the Indemnitor (and the Indemnitor may not challenge the reasonableness of
any such settlement) and (y) in the event of a circumstance described in clauses (iii) or (iv)
above, the Indemnitee may not settle such claim without the consent of the Indemnitor (which
consent will not be unreasonably withheld or delayed). The reasonable expenses of all proceedings,
contests or lawsuits in respect of such claims shall be borne and paid by the Indemnitor if the
Indemnitee is entitled to indemnification hereunder and the Indemnitor shall pay the Indemnitee, in
immediately available funds, the amount of any Losses, within a reasonable time of the incurrence
of such Losses. Regardless of which party shall assume the defense or negotiation of the
settlement of the claim, the parties agree to cooperate fully with one another in connection
therewith. In the event that any Losses incurred by the Indemnitee do not involve payment by the
Indemnitee of a third party claim, then, the Indemnitor shall, within twenty (20) days after
written notice from the Indemnitee specifying the amount of Losses, pay to the Indemnitee, in
immediately available funds, the amount of such Losses. Anything in this Section 5 to the
contrary notwithstanding, the Indemnitor shall not, without the Indemnitee’s prior written consent,
settle or compromise any claim or consent to entry of any judgment in respect thereof which imposes
any future obligation on the Indemnitee or which does not include, as an unconditional term
thereof, the giving by the claimant or plaintiff to the Indemnitee, a release from all liability in
respect of such claim.

     6. Conditions.

          (a) The obligation of each Investor to purchase and acquire the Investor Shares hereunder
shall be subject to the conditions that:

               (1) All representations and warranties of the Company shall be true and correct as of and on
each of the date of this Agreement and the date of the Closing;

               (2) The Company shall have performed all of its obligations hereunder and under the Facility
Agreement theretofore to be performed; and

               (3) The Prospectus shall have been filed with the Commission pursuant to Rule 424(b) within
the applicable time period prescribed for such filing, no stop order suspending the effectiveness
of the Registration Statement or any part thereof shall have been issued and no proceeding for that
purpose shall have been initiated or threatened by the Commission, and the Investor shall have
received the Prospectus in accordance with the federal securities laws.

          (b) The obligation of the Company to enter into this Agreement shall be subject to the
conditions that:

10

 

               (1) All representations and warranties and other statements of the Investors shall be true and
correct as of and on each of the date of this Agreement and the date of the Closing; and

               (2) The Investors shall have performed all of their obligations hereunder and under the
Facility Agreement theretofore to be performed.

     7. Miscellaneous.

          (a) Binding Agreement; Assignment. This Agreement shall be binding upon, and shall
inure solely to the benefit of, each of the parties hereto, and each of their respective heirs,
executors, administrators, successors and permitted assigns, and no other person shall acquire or
have any right under or by virtue of this Agreement. The Company may not assign any of its rights
or obligations hereunder to any other person or entity without the prior written consent of the
Investors.

          (b) Entire Agreement. This Agreement, including Schedules I and II
hereto, and the Facility Agreement constitutes the entire understanding between the parties hereto
with respect to the subject matter hereof and may be amended only by written execution by both
parties. Upon execution by the Company and the Investors, this Agreement shall be binding on each
of the parties hereto.

          (c) Consent To Jurisdiction. THIS AGREEMENT SHALL BE ENFORCED, GOVERNED AND CONSTRUED
IN ALL RESPECTS IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO ITS
CONFLICTS OF LAWS PRINCIPLES OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW
OF SUCH STATE. FURTHERMORE, THE INVESTOR HEREBY IRREVOCABLY SUBMITS TO THE JURISDICTION OF THE
FEDERAL OR STATE COURTS LOCATED IN THE STATE OF NEW YORK IN ANY LEGAL PROCEEDING ARISING OUT OF OR
RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH OF THE COMPANY AND THE
INVESTORS (AND, TO THE EXTENT PERMITTED BY LAW, ON BEHALF OF ITS AND THEIR EQUITY HOLDERS AND
CREDITORS) HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY
JURY IN RESPECT OF ANY CLAIM BASED UPON, ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT AND
THE TRANSACTIONS CONTEMPLATED HEREBY.

          (d) Notices. Any notice, request or other communication to be given or made under
this Agreement shall be in writing. Such notice, request or other communication shall be deemed to
have been duly given or made when it shall be delivered by hand, overnight mail, international
courier (confirmed by facsimile), or facsimile (with a hard copy delivered within two (2) Business
Days) to the Party to which it is required or permitted to be given or made at such Party’s address
specified below or at such other address as such Party shall have designated by notice to the other
Parties.

11

 

For the Borrower:

Insulet Corporation

9 Oak Parks Drive

Bedford, MA 01730

Attention:   R. Anthony Diehl

Facsimile:   (781) 457-5011

with a courtesy copy to:

Goodwin Procter LLP

Exchange Place

Boston, MA 02109

Facsimile:   (617) 523-1231

Attention:   Raymond C. Zemlin

                    Jocelyn M. Arel

For the Lenders c/o:

Deerfield Private Design Fund, L.P.

780 Third Avenue, 37th Floor

New York, New York 10017

Attention:   James E. Flynn

Facsimile:   (212) 573-8111

with a courtesy copy to:

Katten Muchin Rosenman LLP

575 Madison Avenue

New York, New York 10022-2585

Facsimile:   (212) 894-5877

Attention:   Mark I. Fisher

                   Elliot Press

or to such other Person at such other place as the parties shall designate to one another in
writing.

          (e) Counterparts. This Agreement maybe executed in any number of counterparts and by
the parties hereto in separate counterparts, each of which when so executed shall be deemed to be
an original and all of which taken together shall constitute one in the same agreement.

          (f) Telecopy Execution and Delivery. A facsimile, telecopy, PDF or other reproduction
of this Agreement may be executed by one or more parties hereto, and an executed copy of this
Agreement may be delivered by one or more parties by facsimile, e-mail or similar electronic
transmission device pursuant to which the signature of or on behalf of such party can be seen, and
such execution and delivery shall be considered valid, binding and effective for all purposes. At
the request of any party, all parties agree to execute an original of this Agreement

12

 

as well as any facsimile, telecopy or reproduction thereof. The parties hereto hereby agree
that neither shall raise the execution of facsimile, telecopy, PDF or other reproduction of this
Agreement, or the fact that any signature or document was transmitted or communicated by facsimile,
e-mail or similar electronic transmission device, as a defense to the formation of this Agreement.

[Signature pages follow]

13

 

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above.

	 	 	 	 	 	 	 
	 	 	COMPANY:	 	 
	 
	 	 	 	 	 	 
	 	 	INSULET CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Duane DeSisto
 

Duane DeSisto
	 	 
	 

	 	Title:
	 	Chief Executive Officer	 	 
	 
	 	 	 	 	 	 
	 	 	INVESTORS:	 	 
	 
	 	 	 	 	 	 
	 	 	DEERFIELD PRIVATE DESIGN FUND, L.P.	 	 
	 
	 	 	 	 	 	 
	 	 	By:	 	Deerfield Capital, L.P., its General Partner
	 
	 	 	 	 	 	 
	 	 	By:	 	J.E. Flynn Capital LLC, its General Partner
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ James E. Flynn	 	 
	 

	 	Name:
	 	 

James E. Flynn
	 	 
	 

	 	Its:
	 	President	 	 
	 
	 	 	 	 	 	 
	 	 	DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.	 	 
	 
	 	 	 	 	 	 
	 	 	By:	 	Deerfield Capital, L.P., its General Partner
	 
	 	 	 	 	 	 
	 	 	By:	 	J.E. Flynn Capital LLC, its General Partner
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ James E. Flynn
 

James E. Flynn
	 	 
	 

	 	Its:
	 	President	 	 
	 
	 	 	 	 	 	 
	 	 	DEERFIELD PARTNERS, L.P.	 	 
	 
	 	 	 	 	 	 
	 	 	By:	 	Deerfield Capital, L.P., its General Partner
	 
	 	 	 	 	 	 
	 	 	By:	 	J.E. Flynn Capital LLC, its General Partner
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ James E. Flynn	 	 
	 

	 	Name:
	 	 

James E. Flynn
	 	 
	 

	 	Its:
	 	President	 	 

 

 

	 	 	 	 	 	 	 
	 	 	DEERFIELD INTERNATIONAL LIMITED	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ James E. Flynn
 

James E. Flynn
	 	 
	 

	 	Its:
	 	Authorized Signatory	 	 

Schedules I and II to the Securities Purchase Agreement have been omitted in accordance with Item
601(b)(2) of Regulation S-K. Insulet Corporation will furnish supplementally a copy of the omitted
schedules to the Securities and Exchange Commission upon request; provided, however, that Insulet
Corporation may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange
Act of 1934, as amended, for any schedule so furnished.exv10w2

Exhibit 10.2

This Amendment to Facility Agreement (the “Facility Amendment”) contains representations and
warranties that the Lenders (“Lenders”) and Insulet Corporation (“Insulet”) made to each other.
These representations and warranties were made only for the purposes of the signing of the Facility
Amendment and solely for the benefit of the Lenders and Insulet as of specific dates, may be
subject to important limitations and qualifications agreed to by the Lenders and Insulet in
connection with the signing of the Facility Amendment, and may not be complete. Furthermore, these
representations and warranties may have been made for the purposes of allocating contractual risk
between the Lenders and Insulet instead of establishing these matters as facts, and may or may not
have been accurate as of any specific date and do not purport to be accurate as of the date of the
filing of the Facility Amendment by Insulet with the Securities and Exchange Commission.
Accordingly, you should not rely upon the representations and warranties contained in the Facility
Amendment as characterizations of the actual state of facts, since they were intended to be for the
benefit of, and to be limited to, the Lenders and Insulet.

AMENDMENT TO FACILITY AGREEMENT

     AMENDMENT dated September 25, 2009 (this “Amendment”) to the FACILITY AGREEMENT (the
“Agreement”), dated as of March 13, 2009 (the “Agreement Date”), between Insulet
Corporation, a Delaware corporation (the “Borrower”), and those lenders set forth on the
signature page hereof (individually, a “Lender” and together, the “Lenders” and,
collectively with the Borrower, the “Parties”), pursuant to which the Lenders agreed to
lend to the Borrower up to $60,000,000, subject to the terms and conditions set forth in the
Agreement. Capitalized terms used but not otherwise defined herein shall have the respective
meanings assigned to them in the Agreement.

W I T N E S S E T H:

     WHEREAS, on March 31, 2009, the Borrower borrowed from the Lenders an initial Disbursement of
$27,500,000 pursuant to the Agreement (the “Outstanding Principal Amount”);

     WHEREAS, on the date hereof the Borrower and the Lenders have entered into a Securities
Purchase Agreement (the “SPA”), pursuant to which the Lenders have agreed to purchase from
the Borrower, and the Borrower has agreed to issue and sell to the Lenders, shares of the
Borrower’s Common Stock;

     WHEREAS, concurrently with the Closing (as defined in the SPA), the Borrower and the Lenders
desire that the following events will occur: (i) the Borrower will prepay in full the Outstanding
Principal Amount and accrued and unpaid interest thereon to such date, (ii) the Notes issued on
March 13, 2009 by the Borrower to the Lenders in the Outstanding Principal Amount (the
“Original Notes”) will be cancelled and (iii) notwithstanding anything in the Agreement to
the contrary, the Lenders will effect a Disbursement of $32,500,000 to the Borrower pursuant to the
Agreement; and

     WHEREAS, in connection with the foregoing, the Parties desire to amend the Agreement as set
forth herein.

     NOW, THEREFORE, in consideration of the mutual agreements set forth herein, the Lenders and
the Borrower agree as follows:

     1. Concurrently with the Closing: (a) the Borrower shall prepay in full the Outstanding
Principal Amount and accrued and unpaid interest thereon to such date, and upon

 

 

receipt of such
prepayment, the Lenders shall cancel the Original Notes; and (b) notwithstanding anything in the
Agreement to the contrary, the Lenders will effect a Disbursement (the “New Disbursement”)
of $32,500,000 (the “New Principal Amount”) to the Borrower pursuant to the Agreement, and
the Borrower shall deliver to the Lenders Notes for the New Principal Amount in the form attached
hereto as Exhibit A.

     2. Effective as of the Closing:

     (a) The definition of Interest Rate set forth in the Agreement is amended and restated
in its entirety to read as follows: “8.5% simple interest per annum, payable on the
outstanding principal amount of each of the Notes.”

     (b) The definition of Loan set forth in the Agreement is amended to read as follows:
“means the loan to be made available by the Lenders to the Borrower pursuant to Section 2.2
in the amount of thirty-two million five hundred thousand Dollars ($32,500,000)”.

     (c) The definition of Notes in the Agreement is amended and restated in its entirety to
read as follows: “means the notes issued to the Lenders evidencing the Loan in the form
attached hereto as Exhibit A.”

     (d) Section 2.2 of the Agreement (“Disbursements”) is amended and restated in its
entirety to read as follows: “Upon the Closing (as defined in that certain Securities
Purchase Agreement, dated as of September 25, 2009, by and among the Borrower and the
Lenders), the Lenders agree to advance to the Borrower the amount of the Loan (the
“Disbursement”).

     (e) The last sentence of Section 2.3 of the Agreement (“Payments”) is amended to read
as follows: “Except in the event that the Lenders deliver a Put Notice to the Borrower in
accordance with the terms of Section 5.4 of the Agreement, in which case the terms of
Section 5.4 of the Agreement shall apply and no additional amounts per this Section 2.3
shall be due and payable, the Borrower may prepay the Loan at any time upon payment of the
principal amount outstanding and accrued and unpaid interest thereon to the date of
prepayment plus if such prepayment is effected (a) from the date hereof to April 18, 2010,
5% of such principal amount, (b) from April 19, 2010 to October 18, 2010, 4% of such
principal amount, (c) from October 19, 2010 to April 18, 2011, 3% of such principal amount,
(d) from April 19, 2011 to October 18, 2011, 2% of such principal amount, and (e) from and
after October 19, 2011, zero.”

     (f) Section 2.7 of the Agreement (“Costs, Expenses and Losses”) is amended and restated
in its entirety to read as follows: “If, as a result of any failure by the Borrower to pay
any sums due under this Agreement on the due date therefor (after the expiration of any
applicable grace periods), the Lenders shall incur costs, expenses and/or losses, by reason
of the liquidation or redeployment of deposits from third parties or in connection with
obtaining funds to maintain any Disbursement, the Borrower shall pay to the Lenders upon
request by the Lenders, the amount of such costs, expenses and/or losses within fifteen (15)
days after receipt by it of a certificate from the Lenders setting

 

 

forth in reasonable
detail such costs, expenses and/or losses, along with supporting documentation. For the
purposes of the preceding sentence, “costs, expenses and/or losses” shall include, without
limitation, any interest paid or payable to carry any unpaid amount and any loss, premium,
penalty or expense which may be incurred in obtaining, liquidating or employing deposits of
or borrowings from third parties in order to make, maintain or fund the Loan or any portion
thereof.”

     (g) Sections 2.9(b) and 2.9(c) (“Delivery of Warrants”) and 2.9(B) (“Commitment to
Provide Funding Fee”) of the Agreement are deleted.

     (h) Section 5.5 of the Agreement (“General Acceleration Provision upon Events of
Default”) is amended to delete the phrase “cancel the Borrower’s right to request
Disbursements and” from the first sentence thereof.

     (i) Schedule 2 to the Agreement is deleted.

     (j) Exhibit A to the Agreement is replaced by Exhibit A attached
hereto.

     (k) Exhibit B to the Agreement is deleted.

     3. Notwithstanding anything in the Agreement to the contrary, the Borrower’s ability to issue
Disbursement Requests shall terminate as of the date of this Amendment.

     4. Except as amended by this Amendment, the Agreement remains in full force and effect.

     5. The Borrower hereby certifies to the Lenders that the representations and warranties in
Article 3 of the Agreement are true in all material respects on the date hereof with the same
effect as though such representations and warranties had been made on today’s date.

[SIGNATURE PAGE FOLLOWS]

 

 

     IN WITNESS WHEREOF, the undersigned Lender and the Borrowers have caused this Amendment
to be duly executed as of the date first written above.

	 	 	 	 	 
	 	BORROWER:

INSULET CORPORATION

 	 
	 	By:  	/s/ Duane DeSisto
 	 
	 	 	Name:  	Duane DeSisto 	 
	 	 	Title:  	Chief Executive Officer 	 
	 

	 	 	 	 	 
	 	LENDERS:

DEERFIELD PRIVATE DESIGN FUND, L.P.

 	 
	 	By:  	Deerfield Capital, L.P., its General Partner
 	 
	 	 	 
	 	By:  	 J.E. Flynn Capital LLC, its General Partner
 	 
	 	 	 
	 	By:  	 /s/James E. Flynn
 	 
	 	Name:  	James E. Flynn 	 
	 	Its: 	President 	 
	 
	 	DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

 	 
	 	By:  	Deerfield Capital, L.P., its General Partner
 	 
	 	 	 
	 	By:  	 J.E. Flynn Capital LLC, its General Partner
 	 
	 	 	 
	 	By:  	 /s/James E. Flynn
 	 
	 	Name:  	James E. Flynn 	 
	 	Its: 	President 	 
	 
	 	DEERFIELD PARTNERS, L.P.

 	 
	 	By:  	Deerfield Capital, L.P., its General Partner
 	 
	 	 	 
	 	By:  	 J.E. Flynn Capital LLC, its General Partner
 	 
	 	 	 
	 	By:  	 /s/James E. Flynn
 	 
	 	Name:  	James E. Flynn 	 
	 	Its: 	President 	 
	 
	 	DEERFIELD INTERNATIONAL LIMITED

 	 
	 	By:  	/s/James E. Flynn
 	 
	 	Name:  	James E. Flynn 	 
	 	Its: 	Authorized Signatory 	 
	 

Exhibit A (“Form of Note”) to the Amendment to Facility Agreement has been omitted in accordance
with Item 601(b)(2) of Regulation S-K. Insulet Corporation will furnish supplementally a copy of
the omitted exhibit to the Securities and Exchange Commission upon request; provided, however, that
Insulet Corporation may request confidential treatment pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended, for any exhibit so furnished.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}]]